Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
28.51
-0.03 (-0.11%)
At close: Mar 5, 2026, 4:00 PM EST
29.29
+0.78 (2.74%)
Pre-market: Mar 6, 2026, 7:05 AM EST
HRMY Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for HRMY stock have an average target of 46.7, with a low estimate of 28 and a high estimate of 70. The average target predicts an increase of 63.80% from the current stock price of 28.51.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HRMY stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Buy | 4 | 3 | 3 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $46 → $36 | Hold | Maintains | $46 → $36 | +26.27% | Feb 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +92.91% | Feb 25, 2026 |
| B of A Securities | B of A Securities | Sell Maintains $32 → $28 | Sell | Maintains | $32 → $28 | -1.79% | Feb 25, 2026 |
| Needham | Needham | Strong Buy Maintains $46 → $44 | Strong Buy | Maintains | $46 → $44 | +54.33% | Feb 25, 2026 |
| UBS | UBS | Strong Buy → Hold Downgrades $43 → $46 | Strong Buy → Hold | Downgrades | $43 → $46 | +61.35% | Feb 11, 2026 |
Financial Forecast
Revenue This Year
1.04B
from 868.45M
Increased by 19.87%
Revenue Next Year
1.17B
from 1.04B
Increased by 12.49%
EPS This Year
3.62
from 2.71
Increased by 33.68%
EPS Next Year
4.31
from 3.62
Increased by 18.93%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.1B | 1.3B | |||
| Avg | 1.0B | 1.2B | |||
| Low | 964.0M | 918.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 26.9% | 27.8% | |||
| Avg | 19.9% | 12.5% | |||
| Low | 11.0% | -11.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.62 | 6.66 | |||
| Avg | 3.62 | 4.31 | |||
| Low | 2.47 | 3.04 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 70.5% | 83.8% | |||
| Avg | 33.7% | 18.9% | |||
| Low | -8.9% | -16.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.